Paraic A. Kenny
Affiliations: | Developmental and Molecular Biology | Albert Einstein College of Medicine, New York, New York, United States |
Google:
"Paraic Kenny"Parents
Sign in to add mentor| Mina J. Bissell | grad student | Lawrence Berkeley National Lab, UC Berkeley (Chemistry Tree) |
Children
Sign in to add trainee| Edmund C. Jenkins | post-doc | Albert Einstein (Chemistry Tree) | |
| Kristopher A. Lofgren | post-doc | 2013-2015 | Albert Einstein College of Medicine of Yeshiva University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lofgren KA, Kenny PA. (2023) Grb7 knockout mice develop normally but litters born to knockout females fail to thrive. Developmental Dynamics : An Official Publication of the American Association of Anatomists |
| O'Neil SR, Weber GA, Deming DA, et al. (2023) Exceptional Response to Crizotinib With Subsequent Response to Cabozantinib in Metastatic, ROS1-GOPC Fusion-Mutated Breast Cancer. Jco Precision Oncology. 7: e2300174 |
| Lofgren KA, Reker NC, Sreekumar S, et al. (2022) Pan-cancer distribution of cleaved cell-surface amphiregulin, the target of the GMF-1A3 antibody drug conjugate. Antibody Therapeutics. 5: 226-231 |
| Parsons BM, Meier DR, Gurda GT, et al. (2022) Exceptional Response to Crizotinib in an MET-Amplified Triple-Negative Breast Tumor. Jco Precision Oncology. 1: 1-6 |
| Lofgren KA, Sreekumar S, Jenkins EC, et al. (2021) Anti-tumor efficacy of an MMAE-conjugated antibody targeting cell surface TACE/ADAM17-cleaved Amphiregulin in breast cancer. Antibody Therapeutics. 4: 252-261 |
| Parsons BM, Meier DR, Richmond CS, et al. (2020) Acquisition of Cabozantinib-Sensitive MET D1228N Mutation During Progression on Crizotinib in MET-Amplified Triple-Negative Breast Cancer. Clinical Breast Cancer |
| Meier DR, Girtman MA, Lofgren KA, et al. (2019) Amphiregulin deletion strongly attenuates the development of estrogen receptor-positive tumors in p53 mutant mice. Breast Cancer Research and Treatment |
| Mao SPH, Park M, Cabrera RM, et al. (2018) Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth. Breast Cancer Research : Bcr. 20: 131 |
| Emmanuel N, Lofgren KA, Peterson EA, et al. (2018) Mutant GATA3 Actively Promotes the Growth of Normal and Malignant Mammary Cells. Anticancer Research. 38: 4435-4441 |
| Meier DR, Lofgren KA, Gurda GT, et al. (2018) Adaptation of an amplicon-based human cancer next-generation sequencing panel assay for murine tumors. Analytical Biochemistry |